
ãèšåºè©äŸ¡Ãåäœåæãå€§è ¿éªšåæ»è§ãäžãã圱é¿ãæ©è¡ãæããé¢ç¯ãžã®æå€ãªè² æ ã
å€åœ¢æ§è¡é¢ç¯ç޹ä»ãèé¢ç¯çãªã©ãé¢ç¯ãå€åœ¢ãããŠããŸãèŠå ãšããŠã¯äœéããããŸãããä»ã«ããããŸãã
ãã®ïŒã€ã倧è
¿éªšã®éåæ»ãšèšãããŠããŸãã
ã€ãŸããæ£åžžãã倧ããåæ»è§ãšããäºã§ãã
ãã ããããåå ã§ãããšã¯ã£ãããšèšãããŠããããã§ã¯ãªããå¯èœæ§ã®ã²ãšã€ãšããŠèãããããšãããã®ã§ãã
ç ç©¶ã§ã¯ãåæ»è§ã倧ãããšçåãé¢ç¯å¯ååã«åœ±é¿ãäžãããšèšãããŠããŸãã
ã§ã¯ãåäœã«ã¯ã©ã®æ§ãªåœ±é¿ãäžããã®ã§ããããïŒ
ä»å玹ä»ããç ç©¶ã¯ã倧è
¿éªšåæ»è§ãæ©è¡äžã«äžããé¢ç¯ãžã®è² è·ã調æ»ãããã®ã§ãã
å
容ãšããŠã¯ãã¿ã€ãã«ãšã¯è£è
¹ã«ãããç¹ã«ãããŠè² è·ããããäºã蚌æãããŠããŸãã
æãããŠã©ã®ç¹ã§ããããïŒ
ãããŠãä»åã¯æ©è¡ãªã©ã®åäœåæã«é¢ããŠç§èŠã亀ããŠè¿°ã¹ãŠãããããšæããŸãã
ã¿ã€ãã«
âIncreased Femoral Anteversion Does Not Lead to Increased Joint Forces During Gait in a Cohort of Adolescent Patientsâ
æ¥æ¬èªèš³
ã倧è
¿éªšåæ»è§ã®å¢å ã¯ãéå¹Žææ£è
ã®æ©è¡ã«ãããé¢ç¯è² è·ã®å¢å ã«ã€ãªãããªãã
ãšãªããŸãã
ä»åã®èŠç¹ã¯ãã¡ã
ãç ç©¶èŠç¹ã
â å€§è ¿éªšåæ»è§ã®å¢å ã¯ãæ©è¡äžã®è¡é¢ç¯ã»èé¢ç¯ã®è² è·å¢å ãåŒãèµ·ãããªãããšã確èªããã
â èé¢ç¯ã®éå°ãªå±æ²ïŒçµæ«ç«èæã§ã®KneeFlextStå¢å ïŒããèèå€§è ¿é¢ç¯ãžã®è² è·ãå¢å€§ããã
â éçãªå€§è ¿éªšåæ»è§ã®è©äŸ¡ã ãã§ã¯äžååã§ãæ©è¡ãã¿ãŒã³ã®è©äŸ¡ãéèŠã§ãã
ã§ã¯ãèŠçŽã§ãã
1.ãç ç©¶ã®ç®çã
å€§è ¿éªšåæ»è§ã®å¢å ãé¢ç¯ãžã®è² è·ã«ã©ã®ãããªåœ±é¿ãäžããããæ€èšãããããé幎æã®æ£è ã®æ©è¡æã®äžè¢éååŠãé¢ç¯ã¢ãŒã¡ã³ããããã³é¢ç¯åãè©äŸ¡ããã
ã³ã¡ã³ã
å€§è ¿éªšåæ»è§ã«ããé¢ç¯ã®é©åãå€åããããšã§ãè¡é¢ç¯ã§ã«ããŒããããªãéšåãä»ã®é¢ç¯ãžã®è² è·ãšãªãå¯èœæ§ãèããããŸãã
2.ãå¯Ÿè±¡ãšæ¹æ³ã
察象:
å€§è ¿éªšåæ»è§ãå¢å ããæ£è 矀ïŒn = 42, å¹³å12.8æ³, åæ»è§39.6 ± 6.9°ïŒ
å¯Ÿç §çŸ€ïŒn = 9, å¹³å12.0æ³, åæ»è§18.7 ± 4.1°ïŒ
æ¹æ³:
CT/MRIã«ããå€§è ¿éªšåæ»è§ã®æž¬å®
3Dã¢ãŒã·ã§ã³ãã£ããã£ãŒãšåæ¿ãçšããæ©è¡åæ
åå¥ã®çéªšæ Œã¢ãã«ãäœæããè¡é¢ç¯ã»èé¢ç¯ã®é¢ç¯ã¢ãŒã¡ã³ãã»é¢ç¯åãèšç®
çµ±èšçãã©ã¡ããªãã¯ãããã³ã°ïŒSPMïŒãçšããæ¯èŒè§£æ
ã³ã¡ã³ã
å€§è ¿éªšåæ»è§ããããŸã§å€§ããæ¹ã¯ããŸã«ããã£ããããŸããããã®æ¹ã¯èãè¡é¢ç¯ã®çŸæ£ã«ããã£ãŠããæ¹ãå€ãããã«æããŸãã
3.ãäž»ãªçµæã
(1) æ£è 矀ã¯å¯Ÿç §çŸ€ãããé¢ç¯åãäœäž
è¡é¢ç¯ããã³èé¢ç¯ã®å§çž®åãææã«äœäžïŒp < 0.05ïŒ
è¡é¢ç¯ã®å æãè¶³ã®å åãæ©è¡ïŒin-toeingïŒã¯é¢ç¯è² è·ãšé¢é£ããªã
(2) èé¢ç¯çµæ«ç«èæïŒTerminal StanceïŒã§ã®å±æ²è§åºŠãé¢ç¯è² è·ã«åœ±é¿
èã®éå°ãªå±æ²ãããæ£è (æ©è¡è§£æããåé¡)ã¯ã
åé çã®èè骚ãžã®è² è·ãå¢å ïŒp < 0.05ïŒ
èé¢ç¯ã®åŸæ¹åªæåïŒposterior shear forceïŒãå¢å ïŒp < 0.05ïŒ
(3) è¡é¢ç¯ã®å æãè¶³ã®å åãæ©è¡ïŒin-toeingïŒã¯é¢ç¯è² è·ãšé¢é£ããªã
å€§è ¿éªšåæ»è§ã®å¢å ã ãã§ã¯ãé¢ç¯è² è·ã®å¢å€§ãåŒãèµ·ãããªã
åã ã®æ©è¡ãã¿ãŒã³ãé¢ç¯ã®è² è·ã«åœ±é¿ãã

å¯Ÿç §çŸ€ïŒControlïŒãåºæºïŒ100%ïŒãšããŠã
æ£è 矀ïŒéåžžã®KneeFlextStïŒã¯è¡é¢ç¯ã»èé¢ç¯ã®è² è·ãäœäžããåé çåã¯ããå¢å
èã®éå°ãªå±æ²ãæã€æ£è 矀ïŒExcessive KneeFlextStïŒã¯ãåé çã®è² è·ãããã«å¢å ïŒèè骚ãžã®è² è·å¢å€§ïŒ
ãã®ããã«ãèã®éå°ãªå±æ²ãããæ£è ã§ã¯èèå€§è ¿é¢ç¯ã®è² è·ãå¢å ããå¯èœæ§ã瀺åãããã
ã³ã¡ã³ã
è¡é¢ç¯ãèé¢ç¯ãžã®è² è·ã¯å¢ãããããæžã£ãŠãããšã®çµæã¯äºæ³å€ã§ããã圢æ ãããç«èåŸæã§èã®å±æ²ãéå°ã«çãããšããæ©è¡æã®ä»£åãã¿ãŒã³ãè² è·ããããŠããããã§ãã
4.ãèå¯ã
å€§è ¿éªšåæ»è§ã®å¢å ã ãã§ã¯é¢ç¯ã¹ãã¬ã¹ã®å¢å ã«çŽçµããªã
æ©è¡ãã¿ãŒã³ïŒç¹ã«èã®éå°ãªå±æ²ïŒãé¢ç¯è² è·ã«åœ±é¿ãäžãã
æè¡é©å¿ã®å€æã«ã¯ãå€§è ¿éªšåæ»è§ã®éçè©äŸ¡ã ãã§ãªããæ©è¡åæãªã©åçè©äŸ¡ãå¿ èŠ
ã³ã¡ã³ã
æ©è¡ãšããåäœã§ä»£åãçããããšãéåžžã«å€§ããªè² è·ããããããšã«ã€ãªããããã§ããã
5.ãèšåºçæçŸ©ã
åã«å€§è ¿éªšåæ»è§ãå¢å ããŠããã ãã§ã¯æè¡é©å¿ãšãªããªãå¯èœæ§ãé«ã
èé¢ç¯ã®å±æ²è§åºŠãéå°ãªæ£è ã§ã¯ãèèå€§è ¿é¢ç¯ã®è² è·ãå¢å ããããæ³šæãå¿ èŠ
æ©è¡åæã掻çšããæ£è ããšã«åäœè©äŸ¡ãè¡ãããšãéèŠ
ã³ã¡ã³ã
å€§è ¿éªšåæ»è§ã«ç°åžžãªæ¹ã¯æ©è¡ã®ç¹ã«ç«èåŸæã§ã®èã®ã¢ã©ã€ã¡ã³ãã確èªããã¹ãã§ãããéã«èšããšãç«èåŸæã§èãéå°ã«å±æ²äœãåããŠããå Žåã¯å€§è ¿éªšåæ»è§ãå¢å ããŠããå¯èœæ§ãèããããã®ã§ã¯ãªãã§ããããïŒ
6.ããŸãšãïŒåäœåæã®æ¹æ³ã
ãããã§ãããïŒ
ä»åã¯å€§è ¿éªšåæ»è§ãä»ã®é¢ç¯ã«ã©ã®ãããªè² è·ãäžããã®ããšããç ç©¶ã§ããããæ©è¡ã®éã«ç¹ã«åœ±é¿ãåºãããã§ããã
ãã®ç ç©¶ããã代ååäœãšããã®ã¯é¢ç¯ã«éåžžã«å€§ããªè² è·ããããããšã«ã€ãªãããããããããŠé¢ç¯ã®å€åœ¢ãçŒçãšããçç¶ãçããããå¯èœæ§ããããšããããšã ãšæããŸãã
éã«èšããšããããããªãã¿ãŒã³ã§çãã代åãèŠæããæ£åžžãªåäœãã¿ãŒã³ãžãšä¿®æ£ã§ãããšçŒçã軜æžãããããå¯èœæ§ãé«ãŸããšèããããŸãã
åäœãæ£ããèŠããçŒãæã€ããšãå¿
èŠã§ããã
ãŸããæã蟌ã¿ã§èгãªãããã«ããå¿
èŠãããããã§ãã
åäœåæã«é¢ããŠ
ç§ã¯ãæ©è¡ãèŠãéã¯åäœãã¹ã ãŒã¹ã§ãªãããã§ãããããŸãã¿ãŠããŸãã
ã©ããã«çª®å±ãªã ãšæããããéšåããã£ãããäžå®å®ãªæãããããšãã£ãæèŠãã€ãã¿ããããã©ã®é¢ç¯ã§çããŠããã®ããèŠã€ããŸãã
ãããŠãã®éšåãšãå
šäœã®åããçµ±åããŠèããŸãã
äŸãã°ãç«èæã«éå°ã«knee-inããŠããèé¢ç¯çŸæ£ã®æ¹ããããšããŸããèã¯è·éã«äŒŽãæ»ãããŠã窮å±ãªå°è±¡ãåããããšããããŸãã
ãããŠå
šäœãèŠããšãã«äœå¹¹ãknee-inåŽã«åŸæããŠãããšãããšãèéšç矀ã®åããæªããšäºæž¬ãã
èéšç矀ã§ã®è¡é¢ç¯å®å®æ§ãäžååãªçµæknee-inãšããçŸè±¡ãçããããŠãã
ãšèããŸãã
ãã¡ããä»ã®å¯èœæ§ããããŸããããããäžã§è§Šèšºããã®ä»ã®è©äŸ¡ãè¡ããä»®èª¬ãæ€èšŒããŠãããŸãã
ãã®ããã«ãŸãã¯æèŠçã«æããããšãå¿
èŠã ãšæããŸããçããã¯ã©ã®ããã«è¡ã£ãŠããŸããïŒ
æç§æžçãªæ¹æ³ã倧äºã§ããããããå¿çšããæ ¹æ ã®ããèªåãªãã®è©äŸ¡ãšåæã®ææ³ã確ç«ããŠããããšãçŽ æ©ãé©åãªåæãšæ²»çã«ã€ãªããã®ã§ã¯ãªãã§ããããïŒ
以äžã§ç޹ä»ãçµãããŸãã
7.ãåèæç®ã
åèè«æ: Frontiers in Bioengineering and Biotechnology
ãŸãåŠã³ã«ãªãç ç©¶ããããŸããã玹ä»ããŸãããããããé¡ãããŸãã
ãŒå€§è
¿éªšåæ»è§ã«é¢ããŠã¯ãã¡ããã©ãããŒ